2021
DOI: 10.1016/j.humimm.2020.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

4
5

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…Helicobacter pylori is a gram-negative, microaerophilic, and spiral bacterium identified in 1982 (Marshall Warren 1984 ). Helicobacter pylori is recognized as the cause of gastritis, gastrointestinal ulcers and gastric carcinoma (gastric, intestinal ulcers), MALT lymphoma, and non-gastric diseases associated with Helicobacter pylori (Azadegan-Dehkordi et al 2020 ; Fujikawa et al 2003 ; Khaledi et al 2020 ; Lee et al 2005 ; Sanaii et al 2019 ). The outcome of infection with this bacterium depends on several factors such as bacterial isolates, host inflammatory responses, host genetic diversity, and environmental factors (Montecucco de Bernard 2003 ; Nahid-Samiei et al 2020 ; Rhead et al 2007 ; Sanaei et al 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Helicobacter pylori is a gram-negative, microaerophilic, and spiral bacterium identified in 1982 (Marshall Warren 1984 ). Helicobacter pylori is recognized as the cause of gastritis, gastrointestinal ulcers and gastric carcinoma (gastric, intestinal ulcers), MALT lymphoma, and non-gastric diseases associated with Helicobacter pylori (Azadegan-Dehkordi et al 2020 ; Fujikawa et al 2003 ; Khaledi et al 2020 ; Lee et al 2005 ; Sanaii et al 2019 ). The outcome of infection with this bacterium depends on several factors such as bacterial isolates, host inflammatory responses, host genetic diversity, and environmental factors (Montecucco de Bernard 2003 ; Nahid-Samiei et al 2020 ; Rhead et al 2007 ; Sanaei et al 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Several pieces of evidence demonstrated that inhibiting IDO will reduce Kyn/AhR-mediated T reg differentiation, providing an effective strategy for the prevention and treatment of inflammation-related colon cancer, and has reference value for the treatment of GC [ 79 ]. IDO plays an important role in immunosuppressive pathways, and increased expression of IDO proteins can alter the number of Th1, Th17, Th22 and T reg cells, which may lead to an increased risk of peptic ulcer development in patients infected with H. pylori, thereby increases the likelihood of GC [ 80 ]. Compared with other participating enzymes, indoleamine-2,3-dioxygenase 1 (IDO1) plays a decisive role in the decomposition of tryptophan into kynurenine [ 75 , 81 , 82 ].…”
Section: Metabolic Changes In the Microenvironment Of Gcmentioning
confidence: 99%
“…Helicobacter pylori ( H. pylori ) infection is a major bacterial infection worldwide, leading to various gastroduodenal diseases, including chronic gastritis, peptic ulcer disease (PUD), gastric cancer (GC) and MALT (mucosa-associated lymphoid tissue) lymphoma [ 1 , 2 , 3 , 4 ]. However, most infected patients with H. pylori remain asymptomatic, and increased disease risk is related to the genetic diversity of H. pylori strains or inflammatory responses governed by host genetic diversity, or both [ 5 , 6 , 7 ]. In the hostile acidic environment of the stomach, virulence factors play essential roles in the colonization and survival of H. pylori .…”
Section: Introductionmentioning
confidence: 99%